{
    "organizations": [],
    "uuid": "67d677faca0d83ffcad339ac5781a6bd7989f07a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/merck-co-study/mercks-keytruda-succeeds-in-key-lung-cancer-trial-idUSL3N1PB3WZ",
    "ord_in_thread": 0,
    "title": "Merck's Keytruda succeeds in key lung cancer trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - Merck & Co Inc said on Tuesday that a key late-stage study testing its blockbuster drug Keytruda as a treatment for a type of lung cancer was successful.\nThe trial, which tested Keytruda as a first line treatment, met its main goals of preventing cancer from worsening and extending the overall survival of patients with metastatic non-squamous non-small-cell lung cancer.\nKeytruda has previously been approved to treat several forms of cancer including stomach cancer and skin cancer. (Reporting by Tamara Mathias in Bengaluru)\n ",
    "published": "2018-01-16T20:00:00.000+02:00",
    "crawled": "2018-01-17T19:44:48.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "merck",
        "co",
        "inc",
        "said",
        "tuesday",
        "key",
        "study",
        "testing",
        "blockbuster",
        "drug",
        "keytruda",
        "treatment",
        "type",
        "lung",
        "cancer",
        "successful",
        "trial",
        "tested",
        "keytruda",
        "first",
        "line",
        "treatment",
        "met",
        "main",
        "goal",
        "preventing",
        "cancer",
        "worsening",
        "extending",
        "overall",
        "survival",
        "patient",
        "metastatic",
        "lung",
        "cancer",
        "keytruda",
        "previously",
        "approved",
        "treat",
        "several",
        "form",
        "cancer",
        "including",
        "stomach",
        "cancer",
        "skin",
        "cancer",
        "reporting",
        "tamara",
        "mathias",
        "bengaluru"
    ]
}